Clinical Trial Update: A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Lumasiran for advanced Primary Hyperoxaluria Type 1 has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria
• Hyperoxaluria Type

Drugs mentioned

• Lumasiran (lumasiran)

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Primary Hyperoxaluria Type 1, Primary Hyperoxaluria | Phase 3 | Status: COMPLETED | Results posted: 2022-07-12